Nothing Special   »   [go: up one dir, main page]

IL270273B1 - Improved extended release highly loaded drug compositions - Google Patents

Improved extended release highly loaded drug compositions

Info

Publication number
IL270273B1
IL270273B1 IL270273A IL27027319A IL270273B1 IL 270273 B1 IL270273 B1 IL 270273B1 IL 270273 A IL270273 A IL 270273A IL 27027319 A IL27027319 A IL 27027319A IL 270273 B1 IL270273 B1 IL 270273B1
Authority
IL
Israel
Prior art keywords
extended release
highly loaded
drug compositions
loaded drug
improved extended
Prior art date
Application number
IL270273A
Other languages
Hebrew (he)
Other versions
IL270273A (en
IL270273B2 (en
Original Assignee
Lubrizol Advanced Mat Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=62200552&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL270273(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lubrizol Advanced Mat Inc filed Critical Lubrizol Advanced Mat Inc
Publication of IL270273A publication Critical patent/IL270273A/en
Publication of IL270273B1 publication Critical patent/IL270273B1/en
Publication of IL270273B2 publication Critical patent/IL270273B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4458Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL270273A 2017-05-02 2019-10-29 Improved extended release highly loaded drug compositions IL270273B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762500078P 2017-05-02 2017-05-02
PCT/US2018/030380 WO2018204317A1 (en) 2017-05-02 2018-05-01 Improved extended release highly loaded drug compositions

Publications (3)

Publication Number Publication Date
IL270273A IL270273A (en) 2019-12-31
IL270273B1 true IL270273B1 (en) 2023-03-01
IL270273B2 IL270273B2 (en) 2023-07-01

Family

ID=62200552

Family Applications (1)

Application Number Title Priority Date Filing Date
IL270273A IL270273B2 (en) 2017-05-02 2019-10-29 Improved extended release highly loaded drug compositions

Country Status (12)

Country Link
US (2) US20200113839A1 (en)
EP (1) EP3618813B1 (en)
JP (1) JP7132947B2 (en)
KR (1) KR20190139942A (en)
CN (1) CN110709068B (en)
BR (1) BR112019022896A2 (en)
CA (1) CA3062158A1 (en)
CO (1) CO2019013554A2 (en)
ES (1) ES2924236T3 (en)
IL (1) IL270273B2 (en)
PE (1) PE20191795A1 (en)
WO (1) WO2018204317A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109839460A (en) * 2019-03-14 2019-06-04 上海海虹实业(集团)巢湖今辰药业有限公司 A kind of detection method of the Amoxicillin in relation to substance
CN110824066B (en) * 2019-12-09 2022-05-20 北京悦康科创医药科技股份有限公司 Detection method of cefotaxime sodium related substances
JP7300725B2 (en) * 2020-02-27 2023-06-30 日新製薬株式会社 Solid formulation and its manufacturing method
CN112986435B (en) * 2021-02-23 2022-08-05 海南通用三洋药业有限公司 Method for determining related substances of ampicillin sodium and sulbactam sodium for injection

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798053A (en) 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
GB831897A (en) * 1957-07-08 1960-04-06 Bristol Myers Co Antacid preparation and process for making same
US3915921A (en) 1974-07-02 1975-10-28 Goodrich Co B F Unsaturated carboxylic acid-long chain alkyl ester copolymers and tri-polymers water thickening agents and emulsifiers
US4267103A (en) 1978-12-07 1981-05-12 The B. F. Goodrich Company Solvent polymerization of carboxyl containing monomers
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
US5288814A (en) 1992-08-26 1994-02-22 The B. F. Goodrich Company Easy to disperse polycarboxylic acid thickeners
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
JP4454985B2 (en) * 2002-08-08 2010-04-21 第一三共株式会社 Pharmaceutical composition for lowering blood lipids
WO2004069234A1 (en) * 2003-02-05 2004-08-19 Ipca Laboratories Limited Pharmaceutical compositions and process of production thereof
ES2702608T3 (en) * 2004-06-10 2019-03-04 Glatt Air Techniques Inc Pharmaceutical dosage formulation with controlled release matrix
FR2879930B1 (en) * 2004-12-23 2007-08-31 Oralance Pharma Sa NEW GALENIC SYSTEM FOR TRANSPORTING ASSETS, PROCESS FOR PREPARATION AND USE
WO2006082523A2 (en) * 2005-01-25 2006-08-10 Aurobindo Pharma Limited Pharmaceutical sustained release composition of metformin
CA2595988A1 (en) * 2005-01-27 2006-08-03 Alembic Limited Extended release formulation of levetiracetam
US20070148238A1 (en) * 2005-06-23 2007-06-28 Spherics, Inc. Dosage forms for movement disorder treatment
BRPI0612594A2 (en) * 2005-06-29 2010-11-23 Panacea Biotec Ltd modified release pharmaceutical compositions and process for their preparation
CA2653011A1 (en) * 2008-12-03 2010-06-03 Apotex Technologies Inc Method and apparatus for packaging and dispensing pharmaceuticals
JP5662453B2 (en) * 2009-10-02 2015-01-28 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Therapeutic use of pharmaceutical compositions
TWI636783B (en) * 2012-04-18 2018-10-01 友霖生技醫藥股份有限公司 Stable formulations of pitavastatin
WO2015110962A1 (en) * 2014-01-21 2015-07-30 Wockhardt Limited Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and linagliptin or salts thereof

Also Published As

Publication number Publication date
WO2018204317A1 (en) 2018-11-08
CN110709068A (en) 2020-01-17
CN110709068B (en) 2022-11-08
ES2924236T3 (en) 2022-10-05
IL270273A (en) 2019-12-31
US20200113839A1 (en) 2020-04-16
PE20191795A1 (en) 2019-12-24
JP2020518614A (en) 2020-06-25
US20220016035A1 (en) 2022-01-20
EP3618813B1 (en) 2022-07-06
EP3618813A1 (en) 2020-03-11
BR112019022896A2 (en) 2020-05-19
CO2019013554A2 (en) 2020-04-01
KR20190139942A (en) 2019-12-18
CA3062158A1 (en) 2018-11-08
IL270273B2 (en) 2023-07-01
JP7132947B2 (en) 2022-09-07

Similar Documents

Publication Publication Date Title
IL271657A (en) Pharmaceutical compositions
IL269061A (en) Pharmaceutical composition comprising selexipag
IL271986A (en) Pharmaceutical composition
IL287520A (en) Extended release pharmaceutical compositions of levetiracetam
IL271759B1 (en) Pharmaceutical compositions comprising entrectinib
GB201608323D0 (en) Pharmaceutical compositions
GB201712159D0 (en) Pharmaceutical composition
IL270273B1 (en) Improved extended release highly loaded drug compositions
GB201705303D0 (en) Pharmaceutical compositions
SG11202001179YA (en) Pharmaceutical compositions
IL272419A (en) Pharmaceutical composition
PT3583943T (en) Pharmaceutical composition
GB201705305D0 (en) Pharmaceutical compositions
IL263040A (en) Pharmaceutical composition comprising eteplirsen
GB201719447D0 (en) Pharmaceutical composition
GB201705304D0 (en) Pharmaceutical compositions
GB201705306D0 (en) Pharmaceutical compositions
EP3727485C0 (en) Pharmaceutical composition
IL268146A (en) Extended release methazolamide formulation
GB201611920D0 (en) Pharmaceutical compositions
IL272044A (en) Pharmaceutical compositions
ZA202000014B (en) Pharmaceutical compositions
HUE065294T2 (en) Delayed sustained release pharmaceutical compositions
PT3490535T (en) Sustained release composition comprising micronized tolcapone
HUE057830T2 (en) Pharmaceutical composition comprising famitinib